Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ravi Ganapathy
Institution:
International Vaccine Institute
Observed institution:
International Vaccine Institute
ORCID:
0000-0001-5945-3969
Observed ORCID:
0000-0001-5945-3969
OpenAlex ID:
A5078646276
Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial
2024
·
Katerina Rok Song
, Ram Hari Chapagain
, et al.
·
The Lancet Global Health
·
17
PDF
Scalable production and immunogenicity of a cholera conjugate vaccine
2021
·
Suhi Jeon
, Meagan Kelly
, et al.
·
Vaccine
·
16
Rotavirus spike protein ΔVP8* as a novel carrier protein for conjugate vaccine platform with demonstrated antigenic potential for use as bivalent vaccine
2021
·
Wook-Jin Park
, Yeon-Kyung Yoon
, et al.
·
Scientific Reports
·
12
PDF
Development of invasive non-typhoidal Salmonella conjugate vaccines and their evaluation in a trivalent formulation with typhoid conjugate vaccine
2025
·
So Jung An
, Jae Seung Yang
, et al.
·
Vaccine
·
7
Development of a bivalent conjugate vaccine candidate against rotaviral diarrhea and tuberculosis using polysaccharide from Mycobacterium tuberculosis conjugated to ΔVP8* protein from rotavirus
2021
·
Wook-Jin Park
, Yeon-Kyung Yoon
, et al.
·
Vaccine
·
7
Systems serology-based comparison of humoral immune responses induced by liposome or aluminum hydroxide adjuvanted SARS-CoV-2 spike protein
2025
·
Soo Ji Kim
, Taewoo Kim
, et al.
·
Scientific Reports
·
5
PDF
Vaccination of Rabbits with a Cholera Conjugate Vaccine Comprising O-Specific Polysaccharide and a Recombinant Fragment of Tetanus Toxin Heavy Chain Induces Protective Immune Responses against Vibrio cholerae O1
2023
·
Meagan Kelly
, Suhi Jeon
, et al.
·
American Journal of Tropical Medicine and Hygiene
·
1
PDF
Continuous vaccine manufacturing: challenges and technological solutions
2026
·
Ravi Ganapathy
·
Vaccine Insights
Reviews of "Safety, Immunogenicity and Antibody Persistence of a Bivalent Beta-Containing Booster Vaccine"
2022
·
Ravi Ganapathy
, Paul Licciardi
, et al.
PDF
Review 1: "Safety, Immunogenicity and Antibody Persistence of a Bivalent Beta-Containing Booster Vaccine"
2022
·
Ravi Ganapathy
PDF
Show more works
View as search
Works count:
10
Citation count:
68
H-index:
6
I10-index:
3
Year
Topic
Type